Posted inBiotechnology
Posted inGenetics
FDA Accepts for Review Precigen RRP Gene Therapy Candidate
The FDA has granted Priority Review to Precigen’s Biologics License Application (BLA) for its lead candidate PRGN-2012, the company said—a…















